In turn, passive immunization with the Tau antibody against the N-terminal domain of Tau not only reduced Tau pathology but also ameliorated Aβ pathology in triple-transgenic (3×Tg)-AD mice in moderate to severe stages of the disease [113]. This evidence concerns the gene MAPT and Alzheimer disease.